Abstract
Purpose
Inflammation and oxidative stress are involved in the process of chronic renal failure (CRF). CRF patients show indication of sleep disturbances, and the melatonin rhythm, which modulates sleep, is abnormal in these patients; however, it is still unclear whether inflammation could be related to the blockage of melatonin production and sleep disturbances in this population. The aim of this study was to characterize and correlate sleep, the melatonin rhythm, and the levels of the inflammatory cytokines tumor necrosis factor (TNF) and interleukin (IL)-6 in patients with CRF and controls.
Methods
Sleep was evaluated by the “Sleep Quality Index Pittsburgh” (PSQI) questionnaire, and melatonin and cytokine contents in saliva and blood samples, respectively, were analyzed by ELISA.
Results
The CRF group scored higher on the global PSQI, which indicates a lower sleep quality and a higher prevalence of sleep disorders, than the control group. The CRF individuals also showed lower melatonin content than the control groups, both during the day and at night, and lacked rhythmicity in melatonin production. The CRF group also showed higher contents of TNF and IL-6 than the control group and a negative correlation between TNF and melatonin content.
Conclusion
These results suggest that the sleep disorders observed in the CRF group were probably related to the low production of melatonin observed in this population. The high level of TNF, as previously demonstrated in other pathologies, is probably involved in this blockage of melatonin production in CRF.
Similar content being viewed by others
References
Himmelfarb J (2004) Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Semin Dial 17:449–454
Cheung WW, Paik KH, Mak RH (2010) Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 25:711–724. doi:10.1007/s00467-009-1427-z
Carrero JJ, Stenvinkel P (2010) Inflammation in end-stage renal disease—what have we learned in 10 years? Semin Dial 23:498–509. doi:10.1111/j.1525-139X.2010.00784.x
Aperis G, Prakash P, Paliouras C, Papakonstantinou N, Alivanis P (2012) The role of melatonin in patients with chronic kidney disease undergoing haemodialysis. J Ren Care 38:86–92. doi:10.1111/j.1755-6686.2012.00267.x
Koch BC, van der Putten K, Van Someren EJ, Wielders JP, Ter Wee PM, Nagtegaal JE, Gaillard CA (2010) Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study). Nephrol Dial Transplant 25:513–519. doi:10.1093/ndt/gfp493
Markus RP, Ferreira ZS, Fernandes PA, Cecon E (2007) The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources. Neuroimmunomodulation 14:126–133
Arendt J (1988) Melatonin. Clin Endocrinol (Oxf) 29:205–229. doi:10.1111/j.1365-2265.1988.tb00263.x
Zhdanova IV, Lynch HJ, Wurtman RJ (1997) Melatonin: a sleep-promoting hormone. Sleep 20:899–907
Tomás-Zapico C, Coto-Montes A (2005) A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 39:99–104
Szczepanik M (2007) Melatonin and its influence on immune system. J Physiol Pharmacol 58:115–124
Reiter RJ, Paredes SD, Manchester LC, Tan DX (2009) Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 44:175–200. doi:10.1080/10409230903044914
Pinato L, da Silveira Cruz-Machado S, Franco DG, Campos LM, Cecon E, Fernandes PA, Bittencourt JC, Markus RP (2013) Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesis. Brain Struct Funct 220:827–840. doi:10.1007/s00429-013-0686-4
Bertolazi AN, Fagondes SC, Hoff LS, Dartora EG, Miozzo IC, de Barba ME, Barreto SS (2011) Validation of the Brazilian Portuguese version of the Pittsburgh Sleep Quality Index. Sleep Med 12:70–75. doi:10.1016/j.sleep.2010.04.020
Carazo I, Norambuena F, Oliveira C, Sánchez-Vázquez FJ, Duncan NJ (2013) The effect of night illumination, red and infrared light, on locomotor activity, behavior and melatonin of Senegalese sole (Solea senegalensis) broodstock. Physiol Behav 118:201–207. doi:10.1016/j.physbeh.2013.05.032
Parker KP (2003) Sleep disturbances in dialysis patients. Sleep Med Rev 7:131–143
Russcher M, Koch B, Nagtegaal E, van der Putten K, ter Wee P, Gaillard C (2012) The role of melatonin treatment in chronic kidney disease. Front Biosci (Landmark Ed) 17:2644–2656
Novak M, Shapiro CM, Mendelssohn D, Mucsi I (2006) Diagnosis and management of insomnia in dialysis patients. Semin Dial 19:25–31
Koch BC, Nagtegaal JE, Kerkhof GA, ter Wee PM (2009) Circadian sleep-wake rhythm disturbances in end-stage renal disease. Nat Rev Nephrol 5:407–416. doi:10.1038/nrneph.2009.88
Bonnet MH (2005) Acute sleep deprivation. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 4th edn. Elsevier-Saunders, Philadelphia, pp 52–67
Krueger JM, Maide J (1990) A. Short analytical review: sleep as a host defense: its regulation by microbial products and cytokines. Clin Immunol Immunopathol 57:188–189
Wingard DL, Berkman LF (1983) Mortality risk associated with sleep patterns among adults. Sleep 6:102–107
Hostetter TH (2003) Prevention of the development and progression of renal disease. J Am Soc Nephrol 14:144–147
Ruggenenti P, Cravedi P, Remuzzi G (2012) Mechanisms and treatment of CKD. J Am Soc Nephrol 23:1917–1928. doi:10.1681/ASN.2012040390
De Vecchi A, Finazzi S, Padalino R, Santagostino T, Bottaro E, Roma E, Bossi R (2000) Sleep disorders in peritoneal and haemodialysis patients as assessed by a self-administered questionnaire. Int J Artif Organs 23:237–242
Nagtegaal E, Peeters E, Swart W, Smits M, Kerkhof G, van der Meer G (1998) Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Ther Drug Monit 20:181–183
Cecon E, Fernandes PA, Pinato L, Ferreira ZS, Markus RP (2010) Daily variation of constitutively activated nuclear factor kappa B (NFKB) in rat pineal gland. Chronobiol Int 27:52–67. doi:10.3109/07420521003661615
Mayo JC, Sainz RM, Uria H, Antolin I, Esteban MM, Rodriguez C (1998) Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J Pineal Res 24:179–192
Burkhardt S, Reiter RJ, Tan DX, Hardeland R, Cabrera J, Karbownik M (2001) DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. Int J Biochem Cell Biol 33:775–783
Cipolla-Neto J, Amaral FG, Afeche SC, Tan DX, Reiter RJ (2014) Melatonin, energy metabolism, and obesity: a review. J Pineal Res 56:371–381. doi:10.1111/jpi.12137
Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM (2013) Melatonin: buffering the immune system. Int J Mol Sci 14:8638–8683. doi:10.3390/ijms14048638
Acknowledgments
This work was supported by grants from Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP 11/51495-4) and CNPq (480208/2013-1).
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
Author contributions
Conceived and designed the experiments: L.P. and A.R.P. Performed the experiments: A.R.P, N.C.S, and L.P. Analyzed the data: A.R.P, N.C.S, and L.P. Wrote the paper: L.P. and A.R.P.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pinto, A.R., da Silva, N.C. & Pinato, L. Analyses of melatonin, cytokines, and sleep in chronic renal failure. Sleep Breath 20, 339–344 (2016). https://doi.org/10.1007/s11325-015-1240-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-015-1240-9